Press Releases Xlife Sciences AG

Equities

XLS

CH0461929603

Market Closed - Swiss Exchange Other stock markets 09:00:31 16/05/2024 pm IST			5-day change	1st Jan Change
34.3 ^CHF	-3.11%		-2.83%	-31.26%

23/04	Xlife Sciences Posts Higher FY23 Profit; Revenue Falls	MT
29/02	Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xlife Sciences : Praesentation	07/05	PU
Xlife Sciences : Valuation Report 2023	30/04	PU
Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report	30/04	EQ
Xlife Sciences AG Publishes 2023 Annual Report	23/04	EQ
Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland	03/04	EQ
Xlife Sciences AG Expands Collaboration with Department of Health Abu Dhabi, Partners with Thermo Fisher Scientific and Masdar City	05/02	EQ
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline	29/12	EQ
Xlife Sciences AG Achieves Significant Milestone in the Development of Radiodiagnostics for Liver Diseases	22/12	EQ
Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases	20/12	EQ
Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration	18/12	EQ
Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23.3 million	18/23/18	EQ
ESG Report shows status quo and outlines path for future sustainability improvements Media Release Zurich, September 29, 2023	29/23/29	EQ
Xlife Sciences with significant progress in H1 2023	21/23/21	EQ
Collaboration of Xlife Sciences and the Department of Health – Abu Dhabi to drive global innovations in the life sciences sector	17/23/17	EQ
Media Release Zurich, June 20, 2023 Xlife Sciences: shareholders approved all motions at today’s AGM 2023	20/23/20	EQ
Xlife Sciences publishes agenda for Annual General Meeting 2023	26/23/26	EQ
Xlife Sciences: Valuation Report 2022 confirms and emphasizes long-term portfolio potential	27/23/27	EQ
Xlife Sciences publishes 2022 results and 2023 outlook	20/23/20	EQ
Xlife Sciences : Praesentation	17/23/17	PU
Saniva diagnostics receives approval from the US FDA for its medical product NeuroMex	16/23/16	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Xlife Sciences AG

Equities

XLS

CH0461929603

Press Releases

Filters